This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Toxinvent Ou. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Andrus Tasa: Innovator in Cancer Treatment
Introduction
Andrus Tasa is a notable inventor based in Tartu, Estonia. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds. His work focuses on the creation of antibody-drug conjugates that utilize unique anthracycline derivatives.
Latest Patents
Andrus Tasa holds a patent for "Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment." This invention relates to novel anthracycline derivatives that include two oxazolidine cycles. The patent also covers the preparation of these derivatives and their application in antibody-drug conjugates (ADCs) for the prevention and treatment of cancer.
Career Highlights
Throughout his career, Andrus Tasa has worked with various companies, including Toxinvent OÜ and Tbd-Biodiscovery. His expertise in the field has allowed him to contribute to advancements in cancer therapies and drug development.
Collaborations
Andrus has collaborated with notable individuals in his field, including Ain Uustare and Uno Mäeorg. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Andrus Tasa is a prominent figure in the realm of cancer treatment innovations. His dedication to developing novel therapeutic approaches continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile